These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 315267)
41. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S; Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922 [TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in histiocytosis X. Lahey ME Am J Pediatr Hematol Oncol; 1981; 3(1):57-60. PubMed ID: 6972178 [TBL] [Abstract][Full Text] [Related]
43. [So-called histiocytosis X and malignant histiocytosis]. Haas RJ; Janka G; Helmig M; Meister P Onkologie; 1982 Feb; 5(1):4-12. PubMed ID: 6280120 [TBL] [Abstract][Full Text] [Related]
44. Langerhans cell histiocytosis: a retrospective analysis in a Korean tertiary hospital from 2003 to 2012. Kwon SH; Choi JW; Kim HJ; Youn SW J Dermatol; 2013 Oct; 40(10):824-8. PubMed ID: 23957667 [TBL] [Abstract][Full Text] [Related]
45. Langerhans cell histiocytosis: a case report and summary of the current recommendations of the Histiocyte Society. Satter EK; High WA Dermatol Online J; 2008 Mar; 14(3):3. PubMed ID: 18627705 [TBL] [Abstract][Full Text] [Related]
46. Langerhans cell histiocytosis and other disorders of monocyte-histiocyte lineage. Egeler RM; Nesbit ME Crit Rev Oncol Hematol; 1995 Jan; 18(1):9-35. PubMed ID: 7695824 [No Abstract] [Full Text] [Related]
47. Need for a cooperative study: Pulmonary Langerhans cell histiocytosis and its management in adults. McClain KL; Gonzalez JM; Jonkers R; De Juli E; Egeler M Med Pediatr Oncol; 2002 Jul; 39(1):35-9. PubMed ID: 12116077 [TBL] [Abstract][Full Text] [Related]
48. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms]. Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680 [TBL] [Abstract][Full Text] [Related]
52. Delayed diagnosis of pediatric Langerhans' cell histiocytosis: case report and retrospective review of pediatric cases seen at Mayo Clinic. Jarquin-Valdivia AA; Buchhalter J J Child Neurol; 2001 Jul; 16(7):535-8. PubMed ID: 11453455 [TBL] [Abstract][Full Text] [Related]
53. Histiocytosis X revealed by diabetes insipidus and skin lesions. El Fekih N; Kamoun I; Jones M; Remmeh S; Zéglaoui F; Ben Slama C; Fazaa B Am J Dermatopathol; 2013 Jul; 35(5):606-8. PubMed ID: 23538895 [TBL] [Abstract][Full Text] [Related]
55. [Clinical course and therapy of Langerhans cell histiocytosis in children and adults]. Ruzicka T; Evers J Hautarzt; 2003 Feb; 54(2):148-55. PubMed ID: 12590310 [TBL] [Abstract][Full Text] [Related]
56. Langerhans cell histiocytosis: a 10-year review. Shian WJ; Shu SG; Chu HY; Chi CS Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):385-90. PubMed ID: 7942024 [TBL] [Abstract][Full Text] [Related]
57. [Histiocytosis X: localized and disseminated forms. Apropos of 13 cases]. Donat J; Fernández-Delgado R; Fernández L; Jubert A An Esp Pediatr; 1986 Sep; 25(3):190-4. PubMed ID: 3491557 [TBL] [Abstract][Full Text] [Related]